Account
Hero background pattern

Developing the right pricing strategy for your product

We use a variety of pricing techniques and approaches to recommend the optimum value-based pricing for your product.

How can we support you:
Payer Insights
Pricing Strategy
BD Commercial Assessments
Tactical Pricing

We can help you

  • Obtain payer and stakeholder insights into the perceived value of your product
  • Identify the optimal price for your product
  • Determine the global pricing strategy
  • Understand payer evidence requirements to support your value-based pricing and reimbursement strategy
  • Conduct commercial assessments for business development assets
  • Implement pricing tactics to optimize post-launch pricing at a list and net price level
Get in touch

Discover the latest insights

Spain
A closer look at Spain’s new pharmaceutical acce…
Spain is set to implement a comprehensive reform to its law of guarantees and rational use of medici…
Read more
EU HTA process
ISPOR Europe 2024
We’re delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We’ll…
Read more
market access
How to integrate Market Access strategy with evide…
Introduction What is the secret to a successful drug launch? One crucial factor is establishing a cr…
Read more
EU HTA process
ISPOR Europe 2024: Implications of Indication Expa…
We examine the impact of indication expansions on pricing and reimbursement strategies across EU4 an…
Read more
EU HTA process
ISPOR Europe 2024: Evaluating the Capabilities of …
This study investigates the capabilities of AI tools including ChatGPT for conducting pricing and re…
Read more
market access
What does the right market access organisation str…
Effective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei…
Read more
Saudi Arabia’s rise: from emerging market to…
The Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess…
Read more
pharmaceutical law
New German Medicines Research Act: confidential re…
Germany’s new Medicines Research Act allows confidential rebates for pharma companies, but recent am…
Read more
market access
Does price vs volume rule apply for CAR-Ts conside…
We explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a…
Read more
World EPA Congress 2024: Implications of indicatio…
The study explores the complexities of pricing and reimbursement for multi-indication products in th…
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.